The DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index.
Major apoptotic mechanisms and genes involved in apoptosis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
Thornberry, N. A., & Lazebnik, Y. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,887
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
De Cillà, S. D., Farruggio, S., Vujosevic, S., Raina, G., Filippini, D., Gatti, V., Clemente, N., Mary, D., Vezzola, D., Casini, G., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479441 · Cited by 5,136
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
Bootman, M. D., Missiaen, L., Parys, J. B., De Smedt, H., & Casteels, R. (1995) · Biochemical Journal · doi:10.1042/bj3060445 · Cited by 5,120
The Bcl2 family: regulators of the cellular life-or-death switch
Cory, S., & Adams, J. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc883 · Cited by 4,032
Emerging roles of caspase-3 in apoptosis
Porter, A. G., & Jänicke, R. U. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400476 · Cited by 3,855
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
BCL-2 family members and the mitochondria in apoptosis
Gross, A., McDonnell, J. M., & Korsmeyer, S. J. (1999) · Genes & Development · doi:10.1101/gad.13.15.1899 · Cited by 3,641
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
The Pathophysiology of Mitochondrial Cell Death
Green, D. R., & Kroemer, G. (2004) · Science · doi:10.1126/science.1099320 · Cited by 3,418
Principles of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333
Apoptosis, oncosis, and necrosis. An overview of cell death.
Majno, G., & Joris, I. (1995) · PubMed · Cited by 3,306
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
Czabotar, P. E., Lessene, G., Strasser, A., & Adams, J. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3722 · Cited by 3,219 · cited 8×
“Bcl-2 family members, which play important roles in regulating apoptotic signaling, are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, BclXL, BclW, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (B…”
BackgroundInfluentialA novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,165
Inhibition of death receptor signals by cellular FLIP
Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.-L., Schröter, M., Burns, K., Mattmann, C., et al. (1997) · Nature · doi:10.1038/40657 · Cited by 2,563
Yuan, J. (1993) · Cell · doi:10.1016/0092-8674(93)90485-9 · Cited by 2,483
(2001) · PubMed · Cited by 2,381
Tumor necrosis factor signaling
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401189 · Cited by 2,359
TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001008 · Cited by 2,199 · cited 1×
“Mutant p53 proteins can both lose their native tumor suppressor activity and provide active tumor development [152].”
BackgroundDirect Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108 · cited 1×
“Moreover, cytosolic p53 might induce the activation of pro-apoptotic Bax via direct protein-protein interactions [150].”
BackgroundThe TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
Hsu, H., Xiong, J., & Goeddel, D. V. (1995) · Cell · doi:10.1016/0092-8674(95)90070-5 · Cited by 2,012
The first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967 · cited 1×
“p53 acts as tetrameric transcription factor, which controls the expression of a large set of genes involved in significant cellular processes including DNA damage detection, cell cycle arrest, apoptosis, DNA repair, and senescence [134].”
BackgroundLowe, S. W., & Lin, A. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.485 · Cited by 1,876
Genes that mediate breast cancer metastasis to the brain
Bos, P. D., Zhang, X. H.-F., Nadal, C., Shu, W., Gomis, R. R., Nguyen, D. X., Minn, A. J., van de Vijver, M. J., Gerald, W. L., Foekens, J. A., et al. (2009) · Nature · doi:10.1038/nature08021 · Cited by 1,863
Mechanisms of Caspase Activation and Inhibition during Apoptosis
Shi, Y. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00482-3 · Cited by 1,833
Genetic control of programmed cell death in the nematode C. elegans
Ellis, H. (1986) · Cell · doi:10.1016/0092-8674(86)90004-8 · Cited by 1,828
Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family
Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A., & Ashkenazi, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12687 · Cited by 1,793
p53 Has a Direct Apoptogenic Role at the Mitochondria
Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,777
IAP proteins: blocking the road to death's door
Salvesen, G. S., & Duckett, C. S. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm830 · Cited by 1,756
Corpse clearance defines the meaning of cell death
Savill, J., & Fadok, V. (2000) · Nature · doi:10.1038/35037722 · Cited by 1,547
Organelle-specific initiation of cell death pathways
Ferri, K. F., & Kroemer, G. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-e255 · Cited by 1,456
Targeting Apoptosis Pathways in Cancer Therapy
Ghobrial, I. M., Witzig, T. E., & Adjei, A. A. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.3.178 · Cited by 1,330
Biologically active sphingolipids in cancer pathogenesis and treatment
Ogretmen, B., & Hannun, Y. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1411 · Cited by 1,213
Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL
Emery, J. G., McDonnell, P., Burke, M. B., Deen, K. C., Lyn, S., Silverman, C., Dul, E., Appelbaum, E. R., Eichman, C., DiPrinzio, R., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14363 · Cited by 1,184
Caspases 3 and 7: Key Mediators of Mitochondrial Events of Apoptosis
Lakhani, S. A., Masud, A., Kuida, K., Porter, G. A., Booth, C. J., Mehal, W. Z., Inayat, I., & Flavell, R. A. (2006) · Science · doi:10.1126/science.1115035 · Cited by 1,178
Haupt, S., Berger, M., Goldberg, Z., & Haupt, Y. (2003) · Journal of Cell Science · doi:10.1242/jcs.00739 · Cited by 1,136
When mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132
Slee, E. A., Adrain, C., & Martin, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008363200 · Cited by 1,115
Degterev, A., Boyce, M., & Yuan, J. (2003) · Oncogene · doi:10.1038/sj.onc.1207107 · Cited by 1,107
An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif
Crook, N. E., Clem, R. J., & Miller, L. K. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.2168-2174.1993 · Cited by 1,053
Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
Kang, M. H., & Reynolds, C. P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0144 · Cited by 1,016
Srinivasula, S. M., Hegde, R., Saleh, A., Datta, P., Shiozaki, E., Chai, J., Lee, R.-A., Robbins, P. D., Fernandes-Alnemri, T., Shi, Y., et al. (2001) · Nature · doi:10.1038/35065125 · Cited by 1,013
Toxic proteins released from mitochondria in cell death
Saelens, X., Festjens, N., Walle, L. V., Gurp, M. V., Loo, G. V., & Vandenabeele, P. (2004) · Oncogene · doi:10.1038/sj.onc.1207523 · Cited by 986
The Fas Signaling Pathway: More Than a Paradigm
Wajant, H. (2002) · Science · doi:10.1126/science.1071553 · Cited by 957
Martinon, F., & Tschopp, J. (2004) · Cell · doi:10.1016/j.cell.2004.05.004 · Cited by 938
Aggarwal, B. B., Gupta, S. C., & Kim, J. H. (2012) · Blood · doi:10.1182/blood-2011-04-325225 · Cited by 877
Structural and biochemical basis of apoptotic activation by Smac/DIABLO
Chai, J., Du, C., Wu, J.-W., Kyin, S., Wang, X., & Shi, Y. (2000) · Nature · doi:10.1038/35022514 · Cited by 864
The Role of c-FLIP in Modulation of CD95-induced Apoptosis
Scaffidi, C., Schmitz, I., Krammer, P. H., & Peter, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1541 · Cited by 819
Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53
Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J., & Murphy, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106643200 · Cited by 794
Sedger, L. M., & McDermott, M. F. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.016 · Cited by 771
Mitochondrial p53 activates Bak and causes disruption of a Bak–Mcl1 complex
Leu, J. I.-J., Dumont, P., Hafey, M., Murphy, M. E., & George, D. L. (2004) · Nature Cell Biology · doi:10.1038/ncb1123 · Cited by 770
Two Distinct Pathways Leading to Nuclear Apoptosis
Susin, S. A., Daugas, E., Ravagnan, L., Samejima, K., Zamzami, N., Loeffler, M., Costantini, P., Ferri, K. F., Irinopoulou, T., Prévost, M.-C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.571 · Cited by 736
Apoptosis and cancer: mutations within caspase genes
Ghavami, S., Hashemi, M., Ande, S. R., Yeganeh, B., Xiao, W., Eshraghi, M., Bus, C. J., Kadkhoda, K., Wiechec, E., Halayko, A. J., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2009.066944 · Cited by 713
Genetic control of programmed cell death in the Caenorhabditis elegans hermaphrodite germline
Gumienny, T. L., Lambie, E., Hartwieg, E., Horvitz, H. R., & Hengartner, M. O. (1999) · Development · doi:10.1242/dev.126.5.1011 · Cited by 671
Tinel, A., & Tschopp, J. (2004) · Science · doi:10.1126/science.1095432 · Cited by 665
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) Apoptosis Systems
Walczak, H., & Krammer, P. H. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4840 · Cited by 628
BCL-2 family antagonists for cancer therapy
Lessene, G., Czabotar, P. E., & Colman, P. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2658 · Cited by 621
IAPs, RINGs and ubiquitylation
Vaux, D. L., & Silke, J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1621 · Cited by 610
Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis
Los, M., Craen, M. V. D., Penning, L. C., Schenk, H., Westendorp, M., Baeuerle, P. A., Dröge, W., Krammer, P. H., Fiers, W., & Schulze-Osthoff, K. (1995) · Nature · doi:10.1038/375081a0 · Cited by 607
Rosenblatt, J., Raff, M. C., & Cramer, L. P. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00587-5 · Cited by 601
Morphological Features of Cell Death
Ziegler, U., & Groscurth, P. (2004) · Physiology · doi:10.1152/nips.01519.2004 · Cited by 594
Transcriptional Regulation by P53
Beckerman, R., & Prives, C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000935 · Cited by 569
Caspase-9 and APAF-1 form an active holoenzyme
Rodriguez, J., & Lazebnik, Y. (1999) · Genes & Development · doi:10.1101/gad.13.24.3179 · Cited by 569
c-FLIPL is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis
Chang, D. W. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf356 · Cited by 563
PUMA, a potent killer with or without p53
Yu, J., & Zhang, L. (2008) · Oncogene · doi:10.1038/onc.2009.45 · Cited by 554
Liu, X., Li, P., Widlak, P., Zou, H., Luo, X., Garrard, W. T., & Wang, X. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8461 · Cited by 529
Genetic Control of Programmed Cell Death in the Nematode Caenorhabditis Elegans
Horvitz, H. R. (1994) · Apoptosis · doi:10.1007/978-1-4757-9217-1_1 · Cited by 487
The Long Form of FLIP Is an Activator of Caspase-8 at the Fas Death-inducing Signaling Complex
Micheau, O., Thome, M., Schneider, P., Holler, N., Tschopp, J., Nicholson, D. W., Briand, C., & Grütter, M. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206882200 · Cited by 482
Identification of XAF1 as an antagonist of XIAP anti-Caspase activity
Liston, P., Fong, W. G., Kelly, N. L., Toji, S., Miyazaki, T., Conte, D., Tamai, K., Craig, C. G., McBurney, M. W., & Korneluk, R. G. (2001) · Nature Cell Biology · doi:10.1038/35055027 · Cited by 441
Zhou, M., Liu, Z., Zhao, Y., Ding, Y., Liu, H., Xi, Y., Xiong, W., Li, G., Lu, J., Fodstad, O., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.083337 · Cited by 424
BID regulation by p53 contributes to chemosensitivity
Sax, J. K., Fei, P., Murphy, M. E., Bernhard, E., Korsmeyer, S. J., & El-Deiry, W. S. (2002) · Nature Cell Biology · doi:10.1038/ncb866 · Cited by 420 · cited 1×
“Then, apoptosome formation is induced by cytochrome release via Bak and Bax molecules [29].”
BackgroundStructural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1
Qin, H., Srinivasula, S. M., Wu, G., Fernandes-Alnemri, T., Alnemri, E. S., & Shi, Y. (1999) · Nature · doi:10.1038/21124 · Cited by 420
Fulda, S., Küfer, M. U., Meyer, E., van Valen, F., Dockhorn-Dworniczak, B., & Debatin, K.-M. (2001) · Oncogene · doi:10.1038/sj.onc.1204750 · Cited by 404
The Human Anti-apoptotic Proteins cIAP1 and cIAP2 Bind but Do Not Inhibit Caspases
Eckelman, B. P., & Salvesen, G. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510863200 · Cited by 391
Ceramide Channels Increase the Permeability of the Mitochondrial Outer Membrane to Small Proteins
Siskind, L. J., Kolesnick, R. N., & Colombini, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200754200 · Cited by 389
Targeted rescue of a destabilized mutant of p53 by an in silico screened drug
Boeckler, F. M., Joerger, A. C., Jaggi, G., Rutherford, T. J., Veprintsev, D. B., & Fersht, A. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805326105 · Cited by 387
Uncovering the role of p53 splice variants in human malignancy: a clinical perspective
Bourdon, J.-C., Surget, S., & Khoury, M. P. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s53876 · Cited by 382
Chowdhury, I., Tharakan, B., & Bhat, G. K. (2008) · Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2008.05.010 · Cited by 368
NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP
Sun, C., Cai, M., Gunasekera, A. H., Meadows, R. P., Wang, H., Chen, J., Zhang, H., Wu, W., Xu, N., Ng, S.-C., et al. (1999) · Nature · doi:10.1038/44617 · Cited by 343
Yang, Q.-H., Church-Hajduk, R., Ren, J., Newton, M. L., & Du, C. (2003) · Genes & Development · doi:10.1101/gad.1097903 · Cited by 335
Bcl2 family proteins in carcinogenesis and the treatment of cancer
Frenzel, A., Grespi, F., Chmelewskij, W., & Villunger, A. (2009) · Apoptosis · doi:10.1007/s10495-008-0300-z · Cited by 331
Analysis of the composition, assembly kinetics and activity of native Apaf‐1 apoptosomes
Hill, M. M., Adrain, C., Duriez, P. J., Creagh, E. M., & Martin, S. J. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600210 · Cited by 299
Caspase-7: A protease involved in apoptosis and inflammation
Lamkanfi, M., & Kanneganti, T.-D. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.09.013 · Cited by 294
p53 Family and Cellular Stress Responses in Cancer
Pflaum, J., Schlosser, S., & Müller, M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00285 · Cited by 291
Transcriptional Control of the TNF Gene
Falvo, J. V., Tsytsykova, A. V., & Goldfeld, A. E. (2010) · Current Directions in Autoimmunity · doi:10.1159/000289196 · Cited by 281
TRAIL receptor signalling and modulation: Are we on the right TRAIL?
Mahalingam, D., Szegezdi, E., Keane, M., Jong, S. D., & Samali, A. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.11.006 · Cited by 272
MicroRNA regulation of core apoptosis pathways in cancer
Lima, R. T., Busacca, S., Almeida, G. M., Gaudino, G., Fennell, D. A., & Vasconcelos, M. H. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.11.005 · Cited by 260
NMR Structure and Mutagenesis of the Third Bir Domain of the Inhibitor of Apoptosis Protein XIAP
Sun, C., Cai, M., Meadows, R. P., Xu, N., Gunasekera, A. H., Herrmann, J., Wu, J. C., & Fesik, S. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006226200 · Cited by 254
Cues for apoptotic cell engulfment: eat-me, don't eat-me and come-get-me signals
Grimsley, C. (2003) · Trends in Cell Biology · doi:10.1016/j.tcb.2003.10.004 · Cited by 250
The Apoptosome: Heart and Soul of the Cell Death Machine
Chinnaiyan, A. M. (1999) · Neoplasia · doi:10.1038/sj.neo.7900003 · Cited by 250
Modularity in the TNF-receptor family
Naismith, J. H., & Sprang, S. R. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01164-x · Cited by 248
miR-24 Regulates Apoptosis by Targeting the Open Reading Frame (ORF) Region of FAF1 in Cancer Cells
Qin, W., Shi, Y., Zhao, B., Yao, C., Jin, L., Ma, J., & Jin, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009429 · Cited by 247
Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3
Tsang, W. P., & Kwok, T. T. (2008) · Apoptosis · doi:10.1007/s10495-008-0256-z · Cited by 247
Actin cleavage by CPP-32/apopain during the development of apoptosis
Mashima, T., Naito, M., Noguchi, K., Miller, D. K., Nicholson, D. W., & Tsuruo, T. (1997) · Oncogene · doi:10.1038/sj.onc.1200919 · Cited by 245
Activation of caspases-8 and -10 by FLIPL
BOATRIGHT, K. M., DEIS, C., DENAULT, J.-B., SUTHERLIN, D. P., & SALVESEN, G. S. (2004) · Biochemical Journal · doi:10.1042/bj20040809 · Cited by 245
Pop, C., Oberst, A., Drag, M., Van Raam, B. J., Riedl, S. J., Green, D. R., & Salvesen, G. S. (2011) · Biochemical Journal · doi:10.1042/bj20101738 · Cited by 226
Toso, a Cell Surface, Specific Regulator of Fas-Induced Apoptosis in T Cells
Hitoshi, Y., Lorens, J., Kitada, S.-I., Fisher, J., LaBarge, M., Ring, H. Z., Francke, U., Reed, J. C., Kinoshita, S., & Nolan, G. P. (1998) · Immunity · doi:10.1016/s1074-7613(00)80551-8 · Cited by 221
Oncogenic Role of miR-483-3p at the IGF2/483 Locus
Veronese, A., Lupini, L., Consiglio, J., Visone, R., Ferracin, M., Fornari, F., Zanesi, N., Alder, H., D'Elia, G., Gramantieri, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4456 · Cited by 210
MECHANISMS OF APOPTOSIS THROUGH STRUCTURAL BIOLOGY
Yan, N., & Shi, Y. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.012704.131040 · Cited by 208
Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models
Pchejetski, D., Golzio, M., Bonhoure, E., Calvet, C., Doumerc, N., Garcia, V., Mazerolles, C., Rischmann, P., Teissié, J., Malavaud, B., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2702 · Cited by 205
Receptor-Mediated Choreography of Life and Death
Bhardwaj, A., & Aggarwal, B. B. (2003) · Journal of Clinical Immunology · doi:10.1023/a:1025319031417 · Cited by 198
The proteolytic procaspase activation network: an in vitro analysis
Van de Craen, M., Declercq, W., Van den brande, I., Fiers, W., & Vandenabeele, P. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400589 · Cited by 197
Fantuzzi, G., Puren, A. J., Harding, M. W., Livingston, D. J., & Dinarello, C. A. (1998) · Blood · doi:10.1182/blood.v91.6.2118 · Cited by 196
miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222
Acunzo, M., Visone, R., Romano, G., Veronese, A., Lovat, F., Palmieri, D., Bottoni, A., Garofalo, M., Gasparini, P., Condorelli, G., et al. (2012) · Oncogene · doi:10.1038/onc.2011.260 · Cited by 192
von Haefen, C., Wieder, T., Gillissen, B., Stärck, L., Graupner, V., Dörken, B., & Daniel, P. T. (2002) · Oncogene · doi:10.1038/sj.onc.1205497 · Cited by 191
The Structure of FADD and Its Mode of Interaction with Procaspase-8
Carrington, P. E., Sandu, C., Wei, Y., Hill, J. M., Morisawa, G., Huang, T., Gavathiotis, E., Wei, Y., & Werner, M. H. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.04.018 · Cited by 188
Death receptors: Targets for cancer therapy
Mahmood, Z., & Shukla, Y. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.12.011 · Cited by 187
Wang, P., Zhuang, L., Zhang, J., Fan, J., Luo, J., Chen, H., Wang, K., Liu, L., Chen, Z., & Meng, Z. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2012.10.011 · Cited by 186
Stover, T. C., Sharma, A., Robertson, G. P., & Kester, M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1770 · Cited by 179
Targeting BCL2 for the Treatment of Lymphoid Malignancies
Anderson, M. A., Huang, D. C. S., & Roberts, A. W. (2014) · Seminars in Hematology · doi:10.1053/j.seminhematol.2014.05.008 · Cited by 169
TRAIL as a target in anti-cancer therapy
Wu, G. S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.029 · Cited by 168
TRAIL in cancer therapy: present and future challenges
Mérino, D., Lalaoui, N., Morizot, A., Solary, E., & Micheau, O. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.10.1299 · Cited by 168
mir-200c Regulates Induction of Apoptosis through CD95 by Targeting FAP-1
Schickel, R., Park, S.-M., Murmann, A. E., & Peter, M. E. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.018 · Cited by 167
Structure of the human APO‐1 gene
Behrmann, I., Walczak, H., & Krammer, P. H. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241221 · Cited by 165
Cordiali‐Fei, P., Trento, E., Giovanetti, M., Presti, A. L., Latini, A., Giuliani, M., D’Agosto, G., Bordignon, V., Cella, E., Farchi, F., et al. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-014-0119-0 · Cited by 163
Apoptotic threshold is lowered by p53 transactivation of caspase-6
MacLachlan, T. K., & El-Deiry, W. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132241599 · Cited by 162
Inhibitors of Apoptotic Proteins: New Targets for Anticancer Therapy
Saleem, M., Qadir, M. I., Perveen, N., Ahmad, B., Saleem, U., Irshad, T., & Ahmad, B. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12176 · Cited by 155
Curcumin promotes apoptosis in human lung adenocarcinoma cells through miR-186* signaling pathway
Zhang (2010) · Oncology Reports · doi:10.3892/or_00000975 · Cited by 153
Biochemistry of Signal Transduction and Regulation
Krauss, G. (2003) · Wiley eBooks · doi:10.1002/3527601864 · Cited by 148
Puma, a critical mediator of cell death — one decade on from its discovery
Hikisz, P., & Kiliańska, Z. M. (2012) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-012-0032-5 · Cited by 147
Liu, F., Verin, A. D., Wang, P., Day, R. M., Wersto, R. P., Chrest, F. J., English, D. K., & Garcia, J. G. N. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.6.4323 · Cited by 146
MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer
Zhu, Z. (2011) · Oncology Reports · doi:10.3892/or.2011.1530 · Cited by 145
Anti-apoptotic Bcl-2 Family Proteins Disassemble Ceramide Channels
Siskind, L. J., Feinstein, L. H., Yu, T., Davis, J. S., Jones, D., Choi, J., Zuckerman, J. E., Tan, W., Hill, R. B., Hardwick, J. M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706115200 · Cited by 142
Gu, Z., Li, L., Wu, F., Zhao, P. Y., Yang, H. S., Liu, Y. S., Geng, Y., Zhao, M., & Su, L. (2015) · Scientific Reports · doi:10.1038/srep11497 · Cited by 138
Nakano, H., Miyazawa, T., Kinoshita, K., Yamada, Y., & Yoshida, T. (2009) · International Journal of Cancer · doi:10.1002/ijc.25143 · Cited by 136
Beyond apoptosis: caspase regulatory mechanisms and functions in vivo
Kuranaga, E. (2012) · Genes to Cells · doi:10.1111/j.1365-2443.2011.01579.x · Cited by 130
Xu, J., Liao, X., & Wong, C. (2009) · International Journal of Cancer · doi:10.1002/ijc.24823 · Cited by 123
The Drosophila inhibitor of apoptosis D‐IAP1 suppresses cell death induced by the caspase drICE
Kaiser, W. J., Vucic, D., & Miller, L. K. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01465-3 · Cited by 121
Chaturvedi, M., LaPushin, R., & Aggarwal, B. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36662-0 · Cited by 120
microRNA-24a is required to repress apoptosis in the developing neural retina
McGann, J. C., & Harland, R. M. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.05.197 · Cited by 119
Survivin does not inhibit caspase-3 activity
Banks, D. P., Plescia, J., Altieri, D. C., Chen, J., Rosenberg, S. H., Zhang, H., & Ng, S. (2000) · Blood · doi:10.1182/blood.v96.12.4002.h8004000c_4002_4003 · Cited by 114
The unpredictable caspase-2: what can it do?
Vakifahmetoglu-Norberg, H., & Zhivotovsky, B. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.12.006 · Cited by 114
The Regulation of the p53-mediated Stress Response by MDM2 and MDM4
Perry, M. E. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000968 · Cited by 114
Beljanski, V., Lewis, C. S., & Smith, C. D. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.5.14677 · Cited by 112
Floyd, D. H., Zhang, Y., Dey, B. K., Kefas, B. A., Breit, H., Marks, K. T., Dutta, A., Herold‐Mende, C. C., Synowitz, M., Glaß, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096239 · Cited by 110
Hwang, J. J., Kuruvilla, J., Mendelson, D., Pishvaian, M. J., Deeken, J. F., Siu, L. L., Berger, M. S., Viallet, J., & Marshall, J. L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0822 · Cited by 109
Shang, J., Yang, F., Wang, Y., Wang, Y., Xue, G., Mei, Q., Wang, F., & Sun, S. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24721 · Cited by 107
Eto, K., Iwatsuki, M., Watanabe, M., Ida, S., Ishimoto, T., Iwagami, S., Baba, Y., Sakamoto, Y., Miyamoto, Y., Yoshida, N., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3325-7 · Cited by 107
Targeting TRAIL in the treatment of cancer: new developments
Lim, B., Allen, J. E., Prabhu, V. V., Talekar, M. K., Finnberg, N. K., & El‐Deiry, W. S. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1049838 · Cited by 107
Li, J., Xiao, X., Zhang, Y.-N., Wang, Y., Feng, L., Wu, Y., & Zhang, Y. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.09.009 · Cited by 106
Paroni, G., Henderson, C. J., Schneider, C., & Brancolini, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011565200 · Cited by 104
Lymphotoxin and TNF: How it all began—A tribute to the travelers
Ruddle, N. H. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.02.001 · Cited by 102
Coward, J., Ambrosini, G., Musi, E., Truman, J., Haimovitz‐Friedman, A., Allegood, J. C., Wang, E. L., Merrill, A. H., & Schwartz, G. K. (2009) · Autophagy · doi:10.4161/auto.5.2.7361 · Cited by 101
Oncogenic and tumor suppressive roles of microRNAs in apoptosis and autophagy
Chen, Y., Fu, L., Wen, X., Liu, B., Huang, J. M., Wang, J. ‐., & Wei, Y. (2014) · APOPTOSIS · doi:10.1007/s10495-014-0999-7 · Cited by 101
Gocek, E., Wang, X., Liu, X., Liu, C.-G., & Studzinski, G. P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1717 · Cited by 99
Hudson, R. S., Yi, M., Esposito, D., Glynn, S. A., Starks, A. M., Yang, Y., Schetter, A. J., Watkins, S. K., Hurwitz, A. A., Dorsey, T. H., et al. (2013) · Oncogene · doi:10.1038/onc.2012.424 · Cited by 98
Lee, S. Y., Debnath, T., Kim, S., & Lim, B. O. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.07.068 · Cited by 98
Targeting of the Tumor Necrosis Factor Receptor Superfamily for Cancer Immunotherapy
Bremer, E. (2013) · ISRN Oncology · doi:10.1155/2013/371854 · Cited by 95
Genomic Organization and Transcriptional Regulation of Human Apo2/TRAIL Gene
Gong, B., & Almasan, A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3872 · Cited by 94
Trbušek, M., Šmardová, J., Malčíková, J., Šebejová, L., Dobes, P., Svitáková, M., Vranová, V., Mráz, M., Francová, H. S., Doubek, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.7872 · Cited by 93
Regulation of the human TRAIL gene
Allen, J. E., & El‐Deiry, W. S. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.21354 · Cited by 90
Cellular Apoptosis and Organ Injury in Sepsis: A Review
Power, C. P., Fanning, N. F., & Redmond, H. P. (2002) · Shock · doi:10.1097/00024382-200209000-00001 · Cited by 90
Sphingosine Kinase Inhibitors and Cancer: Seeking the Golden Sword of Hercules
Pyne, S., Bittman, R., & Pyne, N. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2364 · Cited by 89
Structural insights into the transcription-independent apoptotic pathway of p53
Chi, S. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.3.261 · Cited by 87
KANG, Y., Kim, W., Bae, H.-U., Kim, D., PARK, Y., PARK, J., Kwon, B. S., & Lee, W. (2005) · Cytokine · doi:10.1016/j.cyto.2004.12.001 · Cited by 85
miR-339-5p regulates the p53 tumor-suppressor pathway by targeting MDM2
Jansson, M., Damas, N. D., Lees, M. J., Jacobsen, A., & Lund, A. H. (2014) · Oncogene · doi:10.1038/onc.2014.130 · Cited by 81
Camisasca, D. R., Honorato, J., Bernardo, V. G., et al. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2008.05.021 · Cited by 81
micro RNA ‐21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells
Satzger, I., Mattern, A., Küttler, U., Weinspach, D., Niebuhr, M., Kapp, A., & Gutzmer, R. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01510.x · Cited by 80
Exploiting death receptor signaling pathways for tumor therapy
Fulda, S., & Debatin, K. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.09.003 · Cited by 80
de Oliveira, J. G., Rossi, A. F. T., Nizato, D. M., Cadamuro, A. C. T., Jorge, Y. C., Valsechi, M. C., Venâncio, L. P. R., Rahal, P., Pavarino, É. C., Goloni‐Bertollo, E. M., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-3593-x · Cited by 77
Ivanov, V. N., Ronai, Z. A., & Hei, T. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509866200 · Cited by 77
The p53 control of apoptosis and proliferation: lessons from Drosophila
Mollereau, B., & Ma, D. (2014) · APOPTOSIS · doi:10.1007/s10495-014-1035-7 · Cited by 76
Etemadi, N., Holien, J. K., Chau, D., Dewson, G., Murphy, J. M., Alexander, W. S., Parker, M. W., Silke, J., & Nachbur, U. (2013) · FEBS Journal · doi:10.1111/febs.12419 · Cited by 74
O’Leary, L., van der Sloot, A. M., Reis, C. R., Deegan, S., Ryan, A. E., Dhami, S. P. S., Murillo, L. S., Cool, R. H., de Sampaio, P. C., Thompson, K., et al. (2015) · Oncogene · doi:10.1038/onc.2015.180 · Cited by 67
Tourneur, L., Mistou, S., Michiels, F.-M., Devauchelle‐Pensec, V., Rénia, L., Feunteun, J., & Chiocchia, G. (2003) · Oncogene · doi:10.1038/sj.onc.1206399 · Cited by 67
Yang, T., Shi, R., Chang, L., Tang, K., Chen, K., Gan, Y., Tian, Y., Guo, Y., He, W., Song, X., et al. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0134-9 · Cited by 66
Nica, A. F., Tsao, C. C., Watt, J. C., Jiffar, T., Kurinna, S. M., Jurasz, P., Konopleva, M. Y., Andreeff, M., Radomski, M. W., & Ruvolo, P. P. (2008) · Cell Cycle · doi:10.4161/cc.7.21.6894 · Cited by 64
Role of BNIP3 in TNF-induced cell death — TNF upregulates BNIP3 expression
Ghavami, S., Eshraghi, M., Kadkhoda, K., Mutawe, M. M., Maddika, S., Bay, G. H., Wesselborg, S., Halayko, A. J., Klonisch, T. C., & Łoś, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.01.002 · Cited by 63
Shen, J., Wan, R., Hu, G., Yang, L., Xiong, J., Wang, F., Shen, J., He, S., Guo, X., Ni, J., et al. (2012) · Pancreatology · doi:10.1016/j.pan.2012.02.008 · Cited by 63
Ebach, D. R., Riehl, T. E., & Stenson, W. F. (2005) · Shock · doi:10.1097/01.shk.0000157301.87051.77 · Cited by 62
Wachter, T., Sprick, M., Hausmann, D., Kerstan, A., McPherson, K., Stassi, G., Bröcker, E., Walczak, H., & Leverkus, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409554200 · Cited by 62
CD95-mediated cell signaling in cancer: mutations and post-translational modulations
Tauzin, S., Debure, L., Moreau, J., & Legembre, P. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0866-4 · Cited by 61
Osteoprotegerin in breast cancer: beyond bone remodeling
Weichhaus, M., Chung, S. T. M., & Connelly, L. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0390-5 · Cited by 60
Akçok, E. B. G., Ural, A. U., Avcu, F., & Baran, Y. (2011) · Annals of Hematology · doi:10.1007/s00277-011-1212-5 · Cited by 57
Self-citationBeckham, T. H., Lü, P., Jones, E. E., Marrison, S. T., Lewis, C. S., Cheng, J., Ramshesh, V. K., Beeson, G. C., Beeson, C., Drake, R. R., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.199216 · Cited by 55
Immunological and Clinical Effects of Vaccines Targeting p53‐Overexpressing Malignancies
Vermeij, R., Leffers, N., van der Burg, S. H., Melief, C. J. M., Daemen, T., & Nijman, H. W. (2011) · BioMed Research International · doi:10.1155/2011/702146 · Cited by 52
Cakir, Z., Saydam, G., Şahin, F., & Baran, Y. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0884-x · Cited by 52
Self-citationMiR-421 Regulates Apoptosis of BGC-823 Gastric Cancer Cells by Targeting Caspase-3
Wu, J.-H., Yao, Y., Gu, T., Wang, Z., Pu, X.-Y., Sun, W., Zhang, X., Jiang, Y.-B., & Wang, J. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.13.5463 · Cited by 50
Ha, J., Shin, J., Yoon, M.-K., Lee, M., He, F., Bae, K., Yoon, H. S., Lee, C., Park, S. G., Muto, Y., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.400754 · Cited by 49
Yandım, M. K., Saydam, G., Şahin, F., & Baran, Y. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2011.538485 · Cited by 48
Self-citationNovel Agents Targeting Bioactive Sphingolipids for the Treatment of Cancer
Adan, A., Yandım, M. K., Iskender, G., & Baran, Y. (2012) · Current Medicinal Chemistry · doi:10.2174/09298673130111 · Cited by 48
Self-citationLane, D. A., Matte, I., Rancourt, C., & Piché, A. (2012) · Journal of Ovarian Research · doi:10.1186/1757-2215-5-34 · Cited by 48
Krieg, A. H., Krieg, T. M., Wenzel, M., Schmitt, M., Ramp, U., Fang, B., Gabbert, H. E., Gerharz, C. D., & Mahotka, C. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600772 · Cited by 43
Sosin, A. M., Burger, A. M., Siddiqi, A., Abrams, J., Mohammad, R. M., & Al-Katib, A. M. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-57 · Cited by 42
Novel Agents Targeting Bioactive Sphingolipids for the Treatment of Cancer
Adan, A., Yandım, M. K., Iskender, G., et al. (2012) · Current Medicinal Chemistry · doi:10.2174/0929867311302010011 · Cited by 42
Self-citationOh, S.-B., Hwang, C. J., Song, S.-Y., Jung, Y. Y., Yun, H.-M., Sok, C. H., Sung, H. C., Yi, J.-M., Park, D. H., Ham, Y. W., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.07.007 · Cited by 41
Huang, W., Tsai, C., Chen, C., Chen, T., Chen, Y., Lin, Y., Lu, P., Lin, C., Wang, S., Tsao, C.-W., et al. (2011) · The FASEB Journal · doi:10.1096/fj.10-180190 · Cited by 41
Lysosomal ceramide mediates gemcitabine-induced death of glioma cells
Dumitru, C. A., Sandalcioglu, I. E., Wagner, M., Weller, M., & Gulbins, E. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0514-8 · Cited by 37
Bake, V., Roesler, S., Eckhardt, I., Belz, K., & Fulda, S. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.08.040 · Cited by 34
Camgöz, A., Akçok, E. B. G., Ural, A. U., & Baran, Y. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.737919 · Cited by 29
Self-citationLow expression of XIAP‐associated factor 1 in human colorectal cancers
Tian Le, M. A., Pei Hua, N. I., Zhong, J., Ji Hong, T. A. N., Min Min, Q. I. A. O., & Jiang, S. H. (2005) · Chinese Journal of Digestive Diseases · doi:10.1111/j.1443-9573.2005.00180.x · Cited by 29
Pal, R., Gochhait, S., Chattopadhyay, S., Gupta, P., Prakash, N., Agarwal, G., Chaturvedi, A., Husain, N., Husain, S. A., & Bamezai, R. N. K. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0900-5 · Cited by 28
Wang, S., Zhou, M., Ouyang, J., Geng, Z., & Wang, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130343 · Cited by 21
Riley, M. F., You, M. J., Multani, A. S., & Lozano, G. (2015) · Oncogene · doi:10.1038/onc.2015.88 · Cited by 20
Camgöz, A., Akçok, E. B. G., Ural, A. U., Avcu, F., & Baran, Y. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.568653 · Cited by 20
Self-citation
Cited by
The double-edged roles of ROS in cancer prevention and therapy
Wang, Y., Qi, H., Liu, Y., Duan, C., Liu, X., Xia, T., Chen, D., Piao, H.-L., & Liu, H.-X. (2021) · Theranostics · doi:10.7150/thno.56747 · Cited by 634
Intrinsic and extrinsic pathways of apoptosis: Role in cancer development and prognosis
(2021) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2021.01.003 · Cited by 402
Hlisníková, H., Petrovičová, I., Kolena, B., Šidlovská, M., & Sirotkin, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17186811 · Cited by 331
The concept of intrinsic versus extrinsic apoptosis
Lossi, L. (2022) · Biochemical Journal · doi:10.1042/bcj20210854 · Cited by 329
Apoptosis in Alzheimer’s disease: Insight into the signaling pathways and therapeutic avenues
Kumari, S., Dhapola, R., & Reddy, D. H. (2023) · Apoptosis · doi:10.1007/s10495-023-01848-y · Cited by 324
Metadata
- Authors
- Kiraz, Y., Adan, A., Kartal Yandim, M., & Baran, Y.
- Venue
- Tumor Biology
- Published
- 2016-04-09
- Volume
- 37
- Issue
- 7
- Pages
- 8471-8486
- ISSN
- 1010-4283 (ISSN-L)
- 1423-0380
- OpenAlex
- W2325008670
- Cited by
- 582
- References
- 203
- FWCI
- 26.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.